Emmaus Life Sciences Inc (EMMA) - Financial and Strategic SWOT Analysis Review
Emmaus Life Sciences Inc (EMMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Emmaus Life Sciences Inc(Emmaus) formerly known as MYnd Analytics Inc, is a predictive analytics company. The company develops a decision support tool that assists physicians in the provision of personalized medication for individual patients suffering from mental health issues. It provides Psychiatric EEG Evaluation Registry (PEER) Online, a cloud-based platform that enables physicians to exchange outcome data for patients referenced to neurophysiology data gathered using a standard electroencephalogram (EEG). Emmaus offers reference data and analytics tools for clinicians and researchers through the company's psychiatric EEG evaluation registry or PEER online. It serves healthcare professionals across the US. Emmaus is headquartered in Mission Viejo, California, the US.
Emmaus Life Sciences Inc Key Recent Developments
Jan 27,2021: Emmaus Life Sciences reports increase in sales volume in 2020
Jan 25,2021: Emmaus Life Sciences Reports annual financial results for 2019 and provides business review
Jul 31,2020: Emmaus Life Sciences provides additional operational and OTC markets updates
Jul 08,2020: Emmaus Life Sciences to restate previously issued financial statements
Jun 02,2020: Emmaus Life Sciences provides operational updates
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Emmaus Life Sciences Inc(Emmaus) formerly known as MYnd Analytics Inc, is a predictive analytics company. The company develops a decision support tool that assists physicians in the provision of personalized medication for individual patients suffering from mental health issues. It provides Psychiatric EEG Evaluation Registry (PEER) Online, a cloud-based platform that enables physicians to exchange outcome data for patients referenced to neurophysiology data gathered using a standard electroencephalogram (EEG). Emmaus offers reference data and analytics tools for clinicians and researchers through the company's psychiatric EEG evaluation registry or PEER online. It serves healthcare professionals across the US. Emmaus is headquartered in Mission Viejo, California, the US.
Emmaus Life Sciences Inc Key Recent Developments
Jan 27,2021: Emmaus Life Sciences reports increase in sales volume in 2020
Jan 25,2021: Emmaus Life Sciences Reports annual financial results for 2019 and provides business review
Jul 31,2020: Emmaus Life Sciences provides additional operational and OTC markets updates
Jul 08,2020: Emmaus Life Sciences to restate previously issued financial statements
Jun 02,2020: Emmaus Life Sciences provides operational updates
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Emmaus Life Sciences Inc - Key Facts
Emmaus Life Sciences Inc - Key Employees
Emmaus Life Sciences Inc - Key Employee Biographies
Emmaus Life Sciences Inc - Major Products and Services
Emmaus Life Sciences Inc - History
Emmaus Life Sciences Inc - Company Statement
Emmaus Life Sciences Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Emmaus Life Sciences Inc - Business Description
Emmaus Life Sciences Inc - Corporate Strategy
Emmaus Life Sciences Inc - SWOT Analysis
SWOT Analysis - Overview
Emmaus Life Sciences Inc - Strengths
Emmaus Life Sciences Inc - Weaknesses
Emmaus Life Sciences Inc - Opportunities
Emmaus Life Sciences Inc - Threats
Emmaus Life Sciences Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Emmaus Life Sciences Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jan 27, 2021: Emmaus Life Sciences reports increase in sales volume in 2020
Jan 25, 2021: Emmaus Life Sciences Reports annual financial results for 2019 and provides business review
Jul 31, 2020: Emmaus Life Sciences provides additional operational and OTC markets updates
Jul 08, 2020: Emmaus Life Sciences to restate previously issued financial statements
Jun 02, 2020: Emmaus Life Sciences provides operational updates
Feb 05, 2020: Emmaus Life Sciences reports preliminary gross sales for the three months ended December 31, 2019
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Emmaus Life Sciences Inc - Key Facts
Emmaus Life Sciences Inc - Key Employees
Emmaus Life Sciences Inc - Key Employee Biographies
Emmaus Life Sciences Inc - Major Products and Services
Emmaus Life Sciences Inc - History
Emmaus Life Sciences Inc - Company Statement
Emmaus Life Sciences Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Emmaus Life Sciences Inc - Business Description
Emmaus Life Sciences Inc - Corporate Strategy
Emmaus Life Sciences Inc - SWOT Analysis
SWOT Analysis - Overview
Emmaus Life Sciences Inc - Strengths
Emmaus Life Sciences Inc - Weaknesses
Emmaus Life Sciences Inc - Opportunities
Emmaus Life Sciences Inc - Threats
Emmaus Life Sciences Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Emmaus Life Sciences Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jan 27, 2021: Emmaus Life Sciences reports increase in sales volume in 2020
Jan 25, 2021: Emmaus Life Sciences Reports annual financial results for 2019 and provides business review
Jul 31, 2020: Emmaus Life Sciences provides additional operational and OTC markets updates
Jul 08, 2020: Emmaus Life Sciences to restate previously issued financial statements
Jun 02, 2020: Emmaus Life Sciences provides operational updates
Feb 05, 2020: Emmaus Life Sciences reports preliminary gross sales for the three months ended December 31, 2019
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Emmaus Life Sciences Inc, Key Facts
Emmaus Life Sciences Inc, Key Employees
Emmaus Life Sciences Inc, Key Employee Biographies
Emmaus Life Sciences Inc, Major Products and Services
Emmaus Life Sciences Inc, History
Emmaus Life Sciences Inc, Subsidiaries
Emmaus Life Sciences Inc, Key Competitors
Emmaus Life Sciences Inc, Ratios based on current share price
Emmaus Life Sciences Inc, Annual Ratios
Emmaus Life Sciences Inc, Annual Ratios (Cont...1)
Emmaus Life Sciences Inc, Interim Ratios
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Emmaus Life Sciences Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Emmaus Life Sciences Inc, Key Facts
Emmaus Life Sciences Inc, Key Employees
Emmaus Life Sciences Inc, Key Employee Biographies
Emmaus Life Sciences Inc, Major Products and Services
Emmaus Life Sciences Inc, History
Emmaus Life Sciences Inc, Subsidiaries
Emmaus Life Sciences Inc, Key Competitors
Emmaus Life Sciences Inc, Ratios based on current share price
Emmaus Life Sciences Inc, Annual Ratios
Emmaus Life Sciences Inc, Annual Ratios (Cont...1)
Emmaus Life Sciences Inc, Interim Ratios
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Emmaus Life Sciences Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Emmaus Life Sciences Inc, Performance Chart (2015 - 2019)
Emmaus Life Sciences Inc, Ratio Charts
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Emmaus Life Sciences Inc, Performance Chart (2015 - 2019)
Emmaus Life Sciences Inc, Ratio Charts
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Emmaus Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021